Form 4: Q32 Bio Inc. Executive Exercises Stock Options

Shelia M. Violette, Chief Scientific Officer of Q32 Bio Inc., exercised stock options and disposed of shares on October 8, 2024.

Summary

• On October 8, 2024, Shelia M. Violette, the Chief Scientific Officer of Q32 Bio Inc., exercised stock options to acquire 13,300 shares of common stock at a price of $3.12 per share.
• Simultaneously, Ms. Violette disposed of 13,300 shares.
• Following the transaction, Ms. Violette directly owns 213 shares and indirectly owns 36,277 shares through Violette Holdings LLC.
• The exercised stock options were fully vested and exercisable as of the transaction date, with an original grant date of December 6, 2028.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider transactions. The sentiment is neutral as it doesn't inherently indicate positive or negative news about the company's performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it reflects an insider's decision to exercise options and sell shares.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is likely negligible.

Key Dates